CD24 and breast carcinoma: In particular, we predicted that CD24 is the target of let-7a and miR-98 with PAOM scores 48.2 and 12.0, respectively, in breast cancer,19 which was previously verified by Kaipparettu et al.19 Further studies will be necessary to verify those findings.